Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Nasser (Lyon, France), P. Rigaud (Lyon, France), K. Ahmad (Lyon, France), J. Traclet (Lyon, France), V. Cottin (Lyon, France). Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression. 2245

Member's Comments

No comment yet.

Related content which might interest you: Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Lymphocytic interstitial pneumonia – a rare underestimated entity of interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 257s Year: 2007 Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans Year: 2013 Diffuse parenchymal lung disease: a different perspective Source: ISSN=ISSN 1810-6838, ISBN=, page=240 Year: 2008 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013 Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Source: Eur Respir J 2001; 18: 17S-29S Year: 2001 Genetic interstitial lung disease: an unusual case Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD? Source: International Congress 2015 – Connective tissue disorders Year: 2015 Cystic interstitial lung disease - a rare disease? Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014